Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies - Cross-sectional and longitudinal experience from the AMORIS cohort

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Malmström, Håkan ^a   Walldius, Göran ^a   Grill, Valdemar ^b,c   Jungner, Ingmar ^a,d   Gudbjörnsdottir, Soffia ^e   Hammar, Niklas ^a,f  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d CALAB Research   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIET RESTRICTION; DISEASE CLASSIFICATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ANALYSIS; BLOOD; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; MIDDLE AGED;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; COHORT STUDIES; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FRUCTOSAMINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED;

EID: 84908611829     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111463     Document Type: Article

References (28)

1. American Diabetes Association (2012) Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 35(1): S64-S71.
2. American Diabetes Association (2013) Standards of Medical Care in Diabetes 2013. Diabetes Care 36(1).
3. Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, et al. (2013) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 34(39): 3035-3087.
4. World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia report of a WHO/IDF consultation. ISBN 92 4 159493 4.
5. World Health Organization (2011) Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus Abbreviated Report of a WHO Consultation. WHO/NMH/CHP/CPM/11.1.
6. Kilpatrick ES (1997) Problems in the assessment of glycaemic control in diabetes mellitus. Diabetes Med 14: 819-31.
7. Cohen RM, Sacks DB (2012) Comparing Multiple Measures of Glycemia: How to Transition from Biomarker to Diagnostic Test?. Clinical Chemistry 58(12): 1615-17.
8. True MW (2009) Circulating Biomarkers of Glycemia in Diabetes Management and Implications for Personalized Medicine. J Diabetes Sci Technol. 3(4): 743-7.
9. Baker JR, Metcalf PA, Johnson RN, Newman D, Rietz P (1985) Use of Protein-Based Standards in Automated Colorimetric Determinations of Fructosamine in Serum. Clin Chem 31(9): 1550-54.
10. Baker JR, O'Connor JP, Metcalf PA, Lawson MR, Johnson RN (1983) Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus. British Medical Journal, 287: 863-67.
11. Baker JR, Metcalf PA, Holdaway IM, Johnson RN (1983) Serum fructosamine concentration as measure of blood glucose control in type I (insulin dependent) diabetes mellitus. British Medical Journal, 290: 352-55.
12. Juraschek SP, Steffes MW, Selvin E (2012) Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose. Clin Chem 58(12): 1648-55.
13. Cohen RM, Holmes YR, Chenier TC, Joiner CH (2013) Discordance Between HbA1c and Fructosamine. Diabetes Care 26(1): 163-67.
14. Ko GTC, Chan JCN, Yeung VTF, Chow CC, Tsang LWW, et al. (1998) Combined Use of a Fasting Plasma Glucose Concentration and HbA1c or Fructosamine Predicts the Likelihood of Having Diabetes in High-Risk Subjects. Diabetes Care 21(8): 1221-5.
15. Selvin E, Rawlings AM, Grams M, Klein R, Sharrett AR, et al. (2014) Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclrosis Risk in Communities (ARIC) study. Lancet Diabetes & Endocrinology 2(4): 279-88.
16. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, et al. (2001) High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358: 2026-2033.
17. Walldius G, Jungner I, Kolar W, Holme I, Steiner E (1992) High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) Study. Blood Pressure 1(4): 35-42.
18. Frank EA, Shubha MC, Cletus D'Souza JM (2012) Blood Glucose Determination: Plasma or Serum? Journal of Clinical Laboratory Analysis 26: 317-320.
19. Johnson RN, Metcalf PA, Baker JR (1982) Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta 127: 87-95.
20. Middle FA, Bannister A, Bellingham AJ, Dean PD (1983) Separation of glycosylated hemoglobins using immobilized phenylboronic acid. Biochem J. 209(3): 771-9.
21. Klenk DC, Hermansson GT, Krohn RI, Fujimoto EK, Mallia AK, et al. (1982) Determination of Glycosylated Hemoglobin by Affinity Chromatography: Comparison with Colorimetric and Ion-Exchange Methods, and Effects of Common Interferences. Clin Chem 28(10): 2088-94.
22. Hoffman-La Roche AG, CH-4002 Basel, Schweiz.
23. Flückiger R, Mortensen HB (1988) Glycated hæmoglobins. J Chromatogr 429: 279-92.
24. Zander R, Lang W, Wolf HU (1984) Alkaline hæmatin D-575, a new tool in the determination of hæmoglobin as an alternative to the Cyanhaemiglobin method I. Description of the method. Clin Chim Acta 136: 83-93.
25. Lamb E, Mainwaring-Burton R, Dawnay A (1991) Effect of protein concentration on the formation of glycated albumin and fructosamine. Clin Chem 37(12): 2138-9.
26. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, et al. (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9): 604-12.
27. Walldius G (2012) The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk. In: Frank S, Kostner G, editors. Lipoproteins in Health and Diseases: ISBN 978-953-51-0773-6. pp. 95-148. http://dx.doi.org/10.5772/47869.
28. Holzmann M, Jungner I, Walldius G, Ivert I, Nordqvist T, et al. (2012) Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease. Ann Med 44(3): 262-70.